|
Mercury
Poisoning
|
Autism
|
|
Psychiatric Disturbances
|
|
|
Social deficits, shyness, social withdrawal
|
Social deficits, social withdrawal, shyness
|
|
Depression, mood swings; mask face
|
Depressive traits, mood swings; flat affect
|
|
Anxiety
|
Anxiety
|
|
Schizoid tendencies, OCD traits
|
Schizophrenic & OCD traits; repetitiveness
|
|
Lacks eye contact, hesitant to engage others
|
Lack of eye contact, avoids conversation
|
|
Irrational fears
|
Irrational fears
|
|
Irritability, aggression, temper tantrums
|
Irritability, aggression, temper tantrums
|
|
Impaired face recognition
|
Impaired face recognition
|
|
Speech, Language & Hearing Deficits
|
|
|
Loss of speech, failure to develop speech
|
Delayed language, failure to develop speech
|
|
Dysarthria; articulation problems
|
Dysarthria; articulation problems
|
|
Speech comprehension deficits
|
Speech comprehension deficits
|
|
Verbalizing & word retrieval problems
|
Echolalia; word use & pragmatic errors
|
|
Sound sensitivity
|
Sound sensitivity
|
|
Hearing loss; deafness in very high doses
|
Mild to profound hearing loss
|
|
Poor performance on language IQ tests
|
Poor performance on verbal IQ tests
|
|
Sensory Abnormalities</TD< tr>
|
|
|
Abnormal sensation in mouth & extremities
|
Abnormal sensation in mouth & extremities
|
|
Sound sensitivity
|
Sound sensitivity
|
|
Abnormal touch sensations; touch aversion
|
Abnormal touch sensations; touch aversion
|
|
Vestibular abnormalities
|
Vestibular abnormalities
|
|
Motor Disorders
|
|
|
Involuntary jerking movements - arm flapping, ankle jerks,
myoclonal jerks, choreiform movements, circling, rocking
|
Stereotyped movements - arm flapping, jumping, circling,
spinning, rocking; myoclonal jerks; choreiform movements
|
|
Deficits in eye-hand coordination; limb apraxia; intention
tremors
|
Poor eye-hand coordination; limb apraxia; problems with
intentional movements
|
|
Gait impairment; ataxia - from incoordination &
clumsiness to inability to walk, stand, or sit; loss of motor control
|
Abnormal gait and posture, clumsiness and incoordination;
difficulties sitting, lying, crawling, and walking
|
|
Difficulty in chewing or swallowing
|
Difficulty chewing or swallowing
|
|
Unusual postures; toe walking
|
Unusual postures; toe walking
|
|
Cognitive Impairments
|
|
|
Borderline intelligence, mental retardation - some cases
reversible
|
Borderline intelligence, mental retardation - sometimes
"recovered"
|
|
Poor concentration, attention, response inhibition
|
Poor concentration, attention, shifting attention
|
|
Uneven performance on IQ subtests
|
Uneven performance on IQ subtests
|
|
Verbal IQ higher than performance IQ
|
Verbal IQ higher than performance IQ
|
|
Poor short term, verbal, & auditory memory
|
Poor short term, auditory & verbal memory
|
|
Poor visual and perceptual motor skills, impairment in
simple reaction time
|
Poor visual and perceptual motor skills, lower performance
on timed tests
|
|
Difficulty carrying out complex commands
|
Difficulty carrying out multiple commands
|
|
Word-comprehension difficulties
|
Word-comprehension difficulties
|
|
Deficits in understanding abstract ideas & symbolism;
degeneration of higher mental powers
|
Deficits in abstract thinking & symbolism,
understanding others mental states, sequencing, planning & organizing
|
|
Unusual Behaviors
|
|
|
Stereotyped sniffing (rats)
|
Stereotyped, repetitive behaviors
|
|
ADHD traits
|
ADHD traits
|
|
Agitation, unprovoked crying, grimacing, staring spells
|
Agitation, unprovoked crying, grimacing, staring spells
|
|
Sleep difficulties
|
Sleep difficulties
|
|
Eating disorders, feeding problems
|
Eating disorders, feeding problems
|
|
Self injurious behavior, e.g. head banging
|
Self injurious behavior, e.g. head banging
|
|
Visual Impairments
|
|
|
Poor eye contact, impaired visual fixation
|
Poor eye contact, problems in joint attention
|
|
Visual impairments, blindness, near-sightedness,
decreased visual acuity
|
Visual impairments; inaccurate/slow saccades; decreased
rod functioning
|
|
Light sensitivity, photophobia
|
Over-sensitivity to light
|
|
Blurred or hazy vision
|
Blurred vision
|
|
Constricted visual fields
|
Not described
|
|
Physical Disturbances
|
|
|
|
|
|
Increase in cerebral palsy; hyper- or hypo-tonia; abnormal
reflexes; decreased muscle strength, especially upper body; incontinence;
problems chewing, swallowing, salivating
|
Increase in cerebral palsy; hyper- or hypotonia; decreased
muscle strength, especially upper body; incontinence; problems chewing and
swallowing
|
|
Rashes, dermatitis/dry skin, itching; burning
|
Rashes, dermatitis, eczema, itching
|
|
Autonomic disturbance: excessive sweating, poor
circulation, elevated heart rate
|
Autonomic disturbance: unusual sweating, poor circulation,
elevated heart rate
|
|
Gastro-intestinal Disturbances</TD<
tr>
|
|
|
Gastroenteritis, diarrhea; abdominal pain, constipation,
colitis
|
Diarrhea, constipation, gaseousness, abdominal discomfort,
colitis
|
|
Anorexia, weight loss, nausea, poor appetite
|
Anorexia; feeding problems/vomiting
|
|
Lesions of ileum & colon; increased gut permeability
|
Leaky gut syndrome
|
|
Inhibits dipeptidyl peptidase IV, which cleaves
casomorphin
|
Inadequate endopeptidase enzymes needed for breakdown of
casein & gluten
|
|
Abnormal Biochemistry
|
|
|
Binds -SH groups; blocks sulfate transporter in
intestines, kidneys
|
Low sulfate levels
|
|
Has special affinity for purines & pyrimidines
|
Purine & pyrimidine metabolism errors lead to autistic
features
|
|
Reduces availability of glutathione, needed in neurons,
cells & liver to detoxify heavy metals
|
Low levels of glutathione; decreased ability of liver to
detoxify heavy metals
|
|
Causes significant reduction in glutathione peroxidase and
glutathione reductase
|
Abnormal glutathione peroxidase activities in erythrocytes
|
|
Disrupts mitochondrial activities, especially in brain
|
Mitochondrial dysfunction, especially in brain
|
|
Immune Dysfunction
|
|
|
Sensitivity due to allergic or autoimmune reactions;
sensitive individuals more likely to have allergies, asthma, autoimmune-like
symptoms, especially rheumatoid-like ones
|
More likely to have allergies and asthma; familial presence
of autoimmune diseases, especially rheumatoid arthritis; IgA deficiencies
|
|
Can produce an immune response in CNS
|
On-going immune response in CNS
|
|
Causes brain/MBP autoantibodies
|
Brain/MBP autoantibodies present
|
|
Causes overproduction of Th2 subset; kills/inhibits
lymphocytes, T-cells, and monocytes; decreases NK T-cell activity; induces or
suppresses IFNg & IL-2
|
Skewed immune-cell subset in the Th2 direction; decreased
responses to T-cell mitogens; reduced NK T-cell function; increased IFNg
& IL-12
|
|
CNS Structural Pathology
|
|
|
Selectively targets brain areas unable to detoxify or
reduce Hg-induced oxidative stress
|
Specific areas of brain pathology; many functions spared
|
|
Damage to Purkinje and granular cells
|
Damage to Purkinje and granular cells
|
|
Accummulates in amygdala and hippocampus
|
Pathology in amygdala and hippocampus
|
|
Causes abnormal neuronal cytoarchitecture; disrupts
neuronal migration & cell division; reduces NCAMs
|
Neuronal disorganization; increased neuronal cell
replication, increased glial cells; depressed expression of NCAMs
|
|
Progressive microcephaly
|
Progressive microcephaly and macrocephaly
|
|
Brain stem defects in some cases
|
Brain stem defects in some cases
|
|
Abnormalities in Neuro-chemistry
|
|
|
Prevents presynaptic serotonin release & inhibits
serotonin transport; causes calcium disruptions
|
Decreased serotonin synthesis in children; abnormal
calcium metabolism
|
|
Alters dopamine systems; peroxidine deficiency in rats
resembles mercurialism in humans
|
Possibly high or low dopamine levels; positive response to
peroxidine (lowers dopamine levels)
|
|
Elevates epinephrine & norepinephrine levels by
blocking enzyme that degrades epinephrine
|
Elevated norepinephrine and epinephrine
|
|
Elevates glutamate
|
Elevated glutamate and aspartate
|
|
Leads to cortical acetylcholine deficiency; increases
muscarinic receptor density in hippocampus & cerebellum
|
Cortical acetylcholine deficiency; reduced muscarinic
receptor binding in hippocampus
|
|
Causes demyelinating neuropathy
|
Demyelination in brain
|
|
EEG Abnormalities / Epilepsy
|
|
|
Causes abnormal EEGs, epileptiform activity
|
Abnormal EEGs, epileptiform activity
|
|
Causes seizures, convulsions
|
Seizures; epilepsy
|
|
Causes subtle, low amplitude seizure activity
|
Subtle, low amplitude seizure activities
|
|
Population Characteristics
|
|
|
Effects more males than females
|
Male:female ratio estimated at 4:1
|
|
At low doses, only affects those geneticially susceptible
|
High heritability - concordance for MZ twins is 90%
|
|
First added to childhood vaccines in 1930s
|
First "discovered" among children born in 1930s
|
|
Exposure levels steadily increased since 1930s with rate
of vaccination, number of vaccines
|
Prevalence of autism has steadily increased from 1 in 2000
(pre1970) to 1 in 500 (early 1990s), higher in 2000.
|
|
Exposure occurs at 0 - 15 months; clinical silent stage
means symptom emergence delayed; symptoms emerge gradually, starting with
movement & sensation
|
Symptoms emerge from 4 months to 2 years old; symptoms
emerge gradually, starting with movement & sensation
|